Cambricon Technologies will pay its maiden dividend after posting its first full-year profit since listing in 2020.

Cambricon Technologies, a Chinese semiconductor designer seen as a potential alternative to US giant Nvidia, will pay its maiden dividend after posting its first full-year profit since listing in 2020. Cambricon, dubbed “little Nvidia”, planned to distribute a cash dividend of 15 yuan (US$2.2) for every 10 shares held, totalling more than 632 million yuan, according to its filing to the Shanghai Stock Exchange on Thursday. Another 20 million yuan would be allocated for share buy-backs, taking the total outlay to 652 million yuan, representing nearly one-third of its 2025 net profit, the company said. The plan has been approved by the board, but is pending shareholders’ approval. After years of operating at a loss, Beijing-based Cambricon swung to a net profit of 2 billion yuan last year, as the company cashed in on the strong demand for chips amid an artificial intelligence boom. Its flagship “Siyuan” series, targeting data centres and cloud-based AI acceleration, has been deployed across multiple server manufacturers. The Siyuan 220 AI chip for edge computing achieved sales of more than 1 million units since its launch in 2019, according to the filing. Cambricon has managed to synchronise compatibility with major Chinese AI models. For example, its chips enabled full support from day one for DeepSeek-V3.2 when the new model was released in December. The company also said that its chips had shown “continuous adaptation” with Alibaba Group Holding’s Qwen3-Next and Qwen3-VL AI models, and with Tencent Holdings’ Hunyuan AI model. Alibaba owns the South China Morning Post.

Physicists at the University of Oxford show they can assemble Schrödinger’s cat-like superpositions from far more exotic quantum ingredients.

Selection marks the next phase of construction on Micron’s New York project, expected to generate 50,000 jobs.

OneAdvanced has launched what it bills as the UK’s first private, sovereign healthcare large language model trained on NHS primary-care data.